(4R,4'R)-2,2'-(1,3-DIPHENYLPROPANE-2,2-DIYL)BIS(4-PHENYL-4,5-DIHYDROOXAZOLE), 95%, 1g

Boc-Lys(2-Cl-Z)-OH, 95%, 50g

(1S,3aR,6aS)-tert-butyl 2-((R)-2-((R)-2-amino-2-cyclohexylacetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylate, 97%, 10mg

4-(2-PYRIDINYL)-THIAZOLE-2-CARBOXYLIC ACID, 97.0%, 250mg

4-((3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)thiomorpholine, 97%, 25g

2-(2-((5-Bromo-2-methylphenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

2-Fluoro-3-methylbenzonitrile, 98.0%, 100g

3,3'-Bis(trifluoromethyl)benzhydrol, 1g

Linaprazan, 99.61%, 50mg

Cyanopyrimidin-2-yl-acetic acid ethyl ester, 95.0%, 100mg

2-Ethoxybenzaldehyde, 95.0%, 100g

3-Bromo-1H-pyrrolo[3,2-c]pyridine, 95.0%, 5g

2-[5-Fluoro-2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl]acetic acid, 1g